Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bei Qi Yi Fei Pian as adjunctive therapy in retreatment pulmonary tuberculosis
CTR20171355Phase 2Active
- Sponsor
- Tonghua Yongcang Pharmaceutical
- Start
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of Beiqi Yifei in pulmonary tuberculosis (TB), sponsored by Tonghua Yongcang Pharmaceutical. Started Jan 2018; status: active.
02
Drugs
Beiqi Yifei
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20171355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171355.